Health benefits of oral contraceptives
- PMID: 11091985
- DOI: 10.1016/s0889-8545(05)70169-8
Health benefits of oral contraceptives
Abstract
A sizeable literature corroborates the multiple health benefits of oral contraceptive use. The first estrogen/progestin combination pills were marketed to treat a variety of menstrual disorders. Although currently used oral contraceptives no longer carry FDA-approved labeling for these indications, they remain important therapeutic options for a variety of gynecologic conditions. Well-established gynecologic benefits include a reduction in dysmenorrhea and menorrhagia, iron-deficiency anemia, ectopic pregnancy, and PID. Although older, higher-dose pills reduced the incidence of ovarian cysts, low-dose pills suppress follicular activity less consistently. Nevertheless, cycle-related symptoms, including functional cysts, dysmenorrhea, chronic pelvic pain, and ovulation pain (mittelschmerz), generally improve. Women with polycystic ovary syndrome note improvement in bleeding patterns and a reduction in acne and hirsutism. Symptoms from endometriosis also improve with oral contraceptive therapy. Current data suggest that oral contraceptive therapy increases bone density and that past use decreases fracture risk. Oral contraceptives also improve acne, a major health concern of young women. Oral contraceptives provide lasting reduction in the risk of two serious gynecologic malignancies--ovarian and endometrial cancer. The data with respect to ovarian cancer are compelling enough to recommend the use of oral contraceptives to women at high risk by virtue of family history, positive carrier status of the BRCA mutations, or nulliparity, even if contraception is not required. Health care providers must counsel women regarding these benefits to counteract deeply held public attitudes and misconceptions regarding oral contraceptive use. Messages should focus on topics of interest to particular groups of women. The fact that oral contraceptives increase bone mineral density and reduce ovarian cancer is of great interest to women in their forties and helps influence use and compliance in this group. In contrast, the beneficial effects of oral contraceptives on acne resonates with younger women. Getting the good news out about the benefits of oral contraceptives will enable more women to take advantage of their positive health effects.
Similar articles
-
Oral contraceptive health benefits: perception versus reality.Contraception. 1999 Jan;59(1 Suppl):29S-33S. doi: 10.1016/s0010-7824(98)00135-8. Contraception. 1999. PMID: 10342094 Review.
-
Noncontraceptive health benefits of oral steroidal contraceptives.Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 2):809-16. doi: 10.1016/s0002-9378(16)32492-9. Am J Obstet Gynecol. 1982. PMID: 7065059
-
Noncontraceptive benefits and therapeutic uses of the oral contraceptive pill.Semin Reprod Med. 2001 Dec;19(4):295-303. doi: 10.1055/s-2001-18637. Semin Reprod Med. 2001. PMID: 11727171 Review.
-
Benefits and risks of oral contraceptive use.Postgrad Med. 1992 Nov 15;92(7):155-7, 161-2, 168-71. doi: 10.1080/00325481.1992.11701539. Postgrad Med. 1992. PMID: 1437913 Review.
-
Therapeutic uses of contraceptive steroids.J Fam Pract. 1984 Sep;19(3):315-21. J Fam Pract. 1984. PMID: 6470632
Cited by
-
Beliefs About Dysmenorrhea and Their Relationship to Self-Management.Res Nurs Health. 2016 Aug;39(4):263-76. doi: 10.1002/nur.21726. Epub 2016 May 13. Res Nurs Health. 2016. PMID: 27177093 Free PMC article.
-
Oral contraceptive use and depression among adolescents.Ann Epidemiol. 2019 Jan;29:46-51. doi: 10.1016/j.annepidem.2018.10.002. Epub 2018 Oct 13. Ann Epidemiol. 2019. PMID: 30674431 Free PMC article.
-
Correlates of menstrual cycle characteristics among nulliparous Danish women.Clin Epidemiol. 2013 Aug 19;5:311-9. doi: 10.2147/CLEP.S46712. eCollection 2013. Clin Epidemiol. 2013. PMID: 23983490 Free PMC article.
-
Giants in Obstetrics and Gynecology Series: A profile of Leon Speroff, MD.Am J Obstet Gynecol. 2017 Sep;217(3):263.e1-263.e8. doi: 10.1016/j.ajog.2017.05.056. Epub 2017 Jul 12. Am J Obstet Gynecol. 2017. PMID: 28710912 Free PMC article. No abstract available.
-
Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland.BMJ Open. 2019 Nov 6;9(11):e031325. doi: 10.1136/bmjopen-2019-031325. BMJ Open. 2019. PMID: 31699733 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous